Skip to main content
. 2023 May 10;72(8):2757–2768. doi: 10.1007/s00262-023-03458-8

Fig. 5.

Fig. 5

Population data for the validation cohort. CCC, cholangiocarcinoma; GB, gallbladder; IPNB, intraductal papillary neoplasm, biliary; PSC, primary sclerosing cholangitis; NET, neuroendocrine tumor; GIST, gastrointestinal stromal tumor